BIOXCEL THERAPEUTICS
BioXcel Therapeutics is a clinical-stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. Its drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. They believe that this differentiated approach has the po... tential to reduce the cost and time of drug development in diseases with substantial unmet medical needs. BXCL501 is a sublingual thin film formulation of the a2a adrenergic receptor agonist dexmedetomidine, or Dex, for acute treatment of agitation resulting from neurological and psychiatric disorders. It intends to utilize the 505(b)(2) pathway for BXCL501, initiated a Phase 1b safety study using the IV formulation of Dex in mild probable Alzheimer's Disease in December 2017, and plans to do the same for schizophrenia patients in the 1H18, with data expected in the 2H18. BXCL701 (formerly Talabostat) is an immuno-oncology agent for the treatment of a rare form of prostate cancer and pancreatic cancer.
BIOXCEL THERAPEUTICS
Industry:
Artificial Intelligence Biopharma Biotechnology Health Care
Founded:
2017-01-01
Address:
Branford, Connecticut, United States
Country:
United States
Website Url:
http://www.bioxceltherapeutics.com
Total Employee:
101+
Status:
Active
Contact:
203 643 8060
Email Addresses:
[email protected]
Total Funding:
140 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Apache Wordpress Plugins Microsoft Exchange Online
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Employees Featured
Founder
Stock Details
Investors List
Qatar Investment Authority
Qatar Investment Authority investment in Post-IPO Debt - BioXcel Therapeutics
Oaktree Capital Management
Oaktree Capital Management investment in Post-IPO Debt - BioXcel Therapeutics
Qatar Investment Authority
Qatar Investment Authority investment in Post-IPO Equity - BioXcel Therapeutics
Oaktree Capital Management
Oaktree Capital Management investment in Post-IPO Equity - BioXcel Therapeutics
Key Employee Changes
Date | New article |
---|---|
2022-01-19 | BioXcel Therapeutics Appoints Matt Wiley Chief Commercial Officer |
Official Site Inspections
http://www.bioxceltherapeutics.com Semrush global rank: 2.05 M Semrush visits lastest month: 10.22 K
- Host name: 20.49.104.33
- IP address: 20.49.104.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "BioXcel Therapeutics"
Overview โ BioXcel Therapeutics Inc
BioXcel Therapeutics, Inc. is a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience.See details»
Board of Directors โ BioXcel Therapeutics Inc
Ms. Bray brings over 40 years of extensive U.S. and global regulatory experience in the healthcare industry. She most recently served as Senior Vice President, Global Regulatory โฆSee details»
BioXcel Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number 203 643 8060 BioXcel Therapeutics is a clinical-stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence (AI) to identify the โฆSee details»
BioXcel Therapeutics, Inc. | LinkedIn
BioXcel Therapeutics, Inc. | 9,488 followers on LinkedIn. Developing transformative medicines in neuroscience using artificial intelligence approaches | Biopharmaceutical company developing ...See details»
Bioxcel
In this position, Dave will work with senior leadership and the board of directors in the development and execution of strategy to drive significant growth within our organization. Prior โฆSee details»
A Brief History of BioXcel Therapeutics โ CBM
3 days ago Website: https://www.bioxceltherapeutics.com; With a commitment to innovation and a passion for improving patient outcomes, BioXcel Therapeutics is poised to make a significant โฆSee details»
BioXcel Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
โ Ayisha Sharma GSK chips in with cash for antibiotic resistance organization: The $66 million in new funds will help the Global Antibiotic Research and Development Partnership speed up โฆSee details»
BioXcel Therapeutics Hosting Virtual Neuroscience R&D Day Today
Dec 12, 2023 To access the Virtual Neuroscience R&D Day presentation, please dial 877-407-5795 (domestic) or 201-689-8722 (international). A live webcast and presentation materials โฆSee details»
BioXcel Therapeutics - Craft
BioXcel Therapeutics has 3 employees at their 1 location and $1.38 m in annual revenue in FY 2023. See insights on BioXcel Therapeutics including office locations, competitors, revenue, โฆSee details»
Advisors โ BioXcel Therapeutics Inc
She most recently served as Chief Medical Officer of Receptos, an immunology-focused biotechnology company acquired by Celgene in 2015 for $7.2 billion. At Receptos, she built โฆSee details»
BioXcel Therapeutics Appoints June Bray to Board of Directors
Mar 1, 2021 โI am excited to join BioXcelโs Board as the Company prepares to transition to a commercial-stage organization,โ said June Bray. โI truly believe BioXcelโs strong neuroscience โฆSee details»
How Does BioXcel Therapeutics Work? โ CBM
3 days ago Website: https://www.bioxceltherapeutics.com; With a commitment to innovation and a focus on improving patient care, BioXcel Therapeutics is poised to make a significant impact โฆSee details»
Press Release - BioXcel Therapeutics
Nov 30, 2023 She joined the Expert Advisory Panel on Drug Dependence for the World Health Organization and has 190 publications on substance use disorders. Event Access To access โฆSee details»
Customer Demographics and Target Market of BioXcel Therapeutics
3 days ago Website: https://www.bioxceltherapeutics.com; Focus: Drug development using artificial intelligence; Mission: Address unmet medical needs and improve patient outcomes; โฆSee details»
AI-based Drug Re-innovation โ BioXcel Therapeutics Inc
Neuroscience is an area in need for innovative treatments โ and one that presents many challenges to drug developers. Designed to address these challenges, our AI-based approach โฆSee details»
Growth Strategy and Future Prospects of BioXcel Therapeutics
3 days ago Website: https://www.bioxceltherapeutics.com; With a commitment to innovation and a focus on leveraging AI technology, BioXcel Therapeutics is well-positioned to drive growth โฆSee details»
Who Owns BioXcel Therapeutics โ CBM
3 days ago Ownership structure plays a significant role in shaping the performance of a company like BioXcel Therapeutics. The way in which ownership is distributed among various โฆSee details»
Comment fonctionne Bioxcel Therapeutics? โ CBM
3 days ago Site web: https://www.bioxceltherapeutics.com; Avec un engagement envers l'innovation et l'accent mis sur l'amélioration des soins aux patients, Bioxcel Therapeutics est โฆSee details»
Una breve historia de la terapéutica bioxcel โ CBM
3 days ago Sitio web: https://www.bioxceltherapeutics.com; Con un compromiso con la innovación y la pasión por mejorar los resultados de los pacientes, Bioxcel Therapeutics está โฆSee details»